“Why Korean companies ignore KRW 130 billion ‘Lipitor’”
While the complex market with statin has led the industry, Korean pharmaceutical companies are known to focus, especially, on R&D for ‘Crestor(generic name: rosuvastatin).’
In this way, the market of combined drugs with statin is mostly divided into rosuvastatin and atorvastatin. Moreover, Korea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
